Cover Image

Family A GPCR heteromers in animal models

Saved in:

Bibliographic Details
Main Author:	Javier eGonzalez-Maeso (Author)
Format:	Book
Published:	Frontiers Media S.A., 2014-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mapping the Interface of a GPCR Dimer: A Structural Model of the A2A Adenosine and D2 Dopamine Receptor Heteromer
by: Dasiel O. Borroto-Escuela, et al.
Published: (2018)

Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs
by: Rafael Franco, et al.
Published: (2023)

Receptor and Channel Heteromers as Pain Targets
by: Kelly A. Berg, et al.
Published: (2012)

Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation and function.
by: Ivone eGomes, et al.
Published: (2014)

Adenosine A2A receptors and A2A receptor heteromers as key players in striatal function
by: Sergi eFerre, et al.
Published: (2011)

Expanding the Concept of G Protein-Coupled Receptor (GPCR) Dimer Asymmetry towards GPCR-Interacting Proteins
by: Ralf Jockers, et al.
Published: (2011)

Screening of GPCR drugs for repurposing in breast cancer
by: Noor Mazin Abdulkareem, et al.
Published: (2022)

GPCR Signaling Regulation: The Role of GRKs and Arrestins
by: Vsevolod V. Gurevich, et al.
Published: (2019)

Structural features of arrestin-mediated GPCR signaling
by: Wenqin Xie, et al.
Published: (2024)

GPCR Conformations: Implications for Rational Drug Design
by: Abby L. Parrill, et al.
Published: (2010)

Discovery of A class GPCR ligands for probing signal transduction pathways
by: Simone eBrogi, et al.
Published: (2014)

Identification of novel GPCR partners of the central melanocortin signaling
by: Yunpeng Li, et al.
Published: (2021)

Functional Consequences of GPCR Heterodimerization: GPCRs as Allosteric Modulators
by: Karla K.V. Haack, et al.
Published: (2011)

Disrupting GPCR Complexes with Smart Drug-like Peptides
by: Maria Gallo, et al.
Published: (2022)

Studying GPCR/cAMP pharmacology from the perspective of cellular structure
by: Peter T Wright, et al.
Published: (2015)

The current status of anti-GPCR drugs against different cancers
by: Sana Usman, et al.
Published: (2020)

Leveraging GPCR signaling in thermogenic fat to counteract metabolic diseases
by: Olivia Sveidahl Johansen, et al.
Published: (2022)

Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors
by: Rishi K. Somvanshi, et al.
Published: (2012)

In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions
by: Sander B. Nabuurs, et al.
Published: (2011)

Biological Redundancy of Endogenous GPCR Ligands in the Gut and the Potential for Endogenous Functional Selectivity
by: Georgina eThompson, et al.
Published: (2014)

The dopamine D1-D2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in basal ganglia
by: Melissa L. Perreault, et al.
Published: (2011)

Genome-wide pan-GPCR cell libraries accelerate drug discovery
by: Hanting Yang, et al.
Published: (2024)

Unlocking the therapeutic capabilities of GPCR in the treatment of ischemic stroke: A translational literature
by: Girish B S, Pharm.D, et al.
Published: (2024)

α1-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α1B/D-adrenoceptors via interference with heteromer formation
by: Xianlong Gao, et al.
Published: (2023)

New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis
by: Anna Bagnato, et al.
Published: (2019)

Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies
by: Martin J. Scott, et al.
Published: (2020)

Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms
by: Haifeng Eishingdrelo, et al.
Published: (2022)

GPCR-mediated natural products and compounds: Potential therapeutic targets for the treatment of neurological diseases
by: Xing Xia Wang, et al.
Published: (2024)

Mind the Gap-Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence
by: Theresa Noonan, et al.
Published: (2022)

GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets
by: Paul A. Insel, et al.
Published: (2018)

A PKA activity sensor for quantitative analysis of endogenous GPCR signaling via 2-photon FRET-FLIM imaging
by: Yao eChen, et al.
Published: (2014)

Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking GPCR Antagonists?
by: Davide Bassani, et al.
Published: (2022)

A simple open source bioinformatic methodology for initial exploration of GPCR ligands' agonistic/antagonistic properties
by: Athanasios A. Panagiotopoulos, et al.
Published: (2020)

Corrigendum: A PKA activity sensor for quantitative analysis of endogenous GPCR signaling via 2-photon FRET-FLIM imaging
by: Yao eChen, et al.
Published: (2016)

Recent advances in understanding adverse effects associated with drugs targeting the serotonin receptor, 5-HT GPCR
by: Isabella Marie Jamu, et al.
Published: (2022)

Integrated bioinformatics analysis reveals that CCBP2 and GPR87 are new GPCR-associated biomarkers for preeclampsia
by: Jie Li, et al.
Published: (2024)

History of the G Protein-Coupled Receptor (GPCR) Assays From Traditional to a State-of-the-Art Biosensor Assay
by: Kanako Miyano, et al.
Published: (2014)

Proposal for describing procedures to correct varicocele. A new terminology
by: Ricardo eGonzález, et al.
Published: (2014)

The Novel Application of Geometric Morphometrics with Principal Component Analysis to Existing G Protein-Coupled Receptor (GPCR) Structures
by: Daniel N. Wiseman, et al.
Published: (2021)

Learn from failures and stay hopeful to GPR40, a GPCR target with robust efficacy, for therapy of metabolic disorders
by: Hong-Ping Guan, et al.
Published: (2022)